Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Perimeter Medical Schedules Q2 2026...
Business earnings call

Perimeter Medical Schedules Q2 2026 Results Call

Analysis based on 7 articles · First reported Aug 13, 2026 · Last updated Aug 13, 2026

Sentiment
0
Attention
0
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement of the upcoming earnings call and the clarification of the completed offering are routine corporate updates with minimal direct market impact. The company's stock may see slight movement around the earnings release date, but the event itself is not expected to significantly affect broader markets.

Medical Devices Healthcare Technology
Event Summary

Perimeter Medical Imaging AI, Inc., a commercial-stage medical technology company, announced on August 13, 2026, that it will report its second quarter 2026 financial and operating results after market close on Thursday, August 20, 2026. Management will host a webcast and conference call to discuss the results and provide a corporate update. The company also clarified the closing of its May 2026 offering, confirming that it issued an additional 1,955,500 units at $0.35 per unit for gross proceeds of C$684,425 on May 8, 2026, as the final tranche of its listed issuer financing exemption offering. This brought the total offering to 21,489,000 units (C$7,521,150). The company also paid an additional cash commission of approximately C$47,910 and issued 136,885 broker warrants. Perimeter Medical Imaging AI is based in Toronto, Canada and Dallas, Texas, and its Claire OCT System, an AI-enabled device for breast cancer surgery, was recently approved by the United States — Food and Drug Administration.

Key Actions
70 Perimeter Medical Imaging AI issued units
40 Perimeter Medical Imaging AI paid commission
30 Perimeter Medical Imaging AI scheduled earnings call
Entities Involved
stock
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI is the central entity, announcing its Q2 2026 earnings call and clarifying the completion of its May 2026 offering. The company's financial results and corporate update will be closely watched by investors.
Importance 100.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration recently approved Perimeter's Claire OCT System, which is a key product for the company. This approval is a significant regulatory milestone but is not the focus of this announcement.
Importance 20.0 Sentiment 0.0
exch
TSX Venture Exchange
TSX Venture Exchange is the listing exchange for Perimeter Medical Imaging AI's common shares. The company's compliance with exchange regulations is noted, but the exchange itself is not directly impacted.
Importance 10.0 Sentiment 0.0
curr
Canada — Canadian dollar
The Canada — Canadian dollar is the currency in which Perimeter's offering proceeds are denominated. The company raised C$7,521,150 in total, and currency fluctuations could affect its financial results.
Importance 10.0 Sentiment 0.0
exch
OTC Markets Group
OTC Markets Group is the alternative trading platform where Perimeter Medical Imaging AI's shares are also quoted. The company's continued listing on OTC Markets Group is part of its market presence.
Importance 10.0 Sentiment 0.0
per
Adrian Mendes
Adrian Mendes is the Chief Executive Officer of Perimeter Medical Imaging AI and will likely participate in the earnings call. His leadership is important for the company's strategic direction.
Importance 10.0 Sentiment 0.0
cnt
United States
The United States is the market where Perimeter's FDA-approved device is sold, and the company has operations in Dallas, Texas. The U.S. market is crucial for the company's commercial success.
Importance 5.0 Sentiment 0.0
per
Stephen Kilmer
Stephen Kilmer is the Investor Relations contact for Perimeter Medical Imaging AI. He is involved in communicating with investors but has no direct impact on the event.
Importance 5.0 Sentiment 0.0
cnt
Canada
Canada is the home country of Perimeter Medical Imaging AI, with operations in Toronto. The company's activities are subject to Canadian securities regulations.
Importance 5.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ United States
United States — Food and Drug Administration related ↔ Canada
TSX Venture Exchange related ↔ OTC Markets Group
TSX Venture Exchange related ↔ United States
TSX Venture Exchange related ↔ Canada
OTC Markets Group related ↔ United States
OTC Markets Group related ↔ Canada
United States trade rivals ↔ Canada The United States views Canada as a key defense partner but also a trade rival, having imposed tariffs and declined to r
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.